Sonoma Pharmaceuticals, Inc. (SNOA) › Gross ProfitSonoma Pharmaceuticals, Inc. (SNOA) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2011: $6.14M2012: $8.71M2013: $10.74M2014: $8.40M2015: $7.29M2016: $2.65M2017: $5.67M2018: $7.31M2019: $8.88M2020: $8.12M2021: $6.56M2022: $3.99M2023: $4.48M2024: $4.75M2025: $5.46M2026: $7.42M$7.42M2011Gross Profit (USD)2026Fiscal YearGross ProfitChange YoY2026$7.42M+35.7%2025$5.46M+15.2%2024$4.75M+6.0%2023$4.48M+12.1%2022$3.99M-39.1%2021$6.56M-19.2%2020$8.12M-8.5%2019$8.88M+21.5%2018$7.31M+29.0%2017$5.67M+114.0%2016$2.65M-63.7%2015$7.29M-13.2%2014$8.40M-21.8%2013$10.74M+23.3%2012$8.71M+41.9%2011$6.14M—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share